drugset / Trial / NCT06666621

Endogenous Opioid Response to Injections

NCT06666621

NaSingle-groupOpen-labelDiagnostic

Summary

This study will study pain relief after spine injections that are used to guide care. Some improvements in pain from a procedure might be from placebo effect rather than the physiological effect of the procedure. The study will use naloxone to reverse the effect of the body's internal placebo system after a spine injection, so the placebo effect and the injection effect can be measured separately. This process may improve the understanding of spine injections and their ability to guide pain care.

Timeline

Start
2024-08-22
Primary completion
2025-10
Completion
2026-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule 8 mg Intravenous